Itex Gliklazide Tablets

Adult dose

[Tablet (Capsule)] Adults start with gliklazide at 40–80mg per day, administered orally once or twice a day. Depending on the patient's blood sugar level, up to 320mg can be administered in two divided doses, and no more than 160mg at one time. In cases of obesity or inadequate response, additional treatment may be necessary. [Extended-release formulation] Adults take gliklazide at 30–120mg once daily, adjusted according to blood glucose levels.

This medication is a sulfonylurea, and there is a risk of hypoglycemia, so the dosage and administration must be strictly followed. Hypoglycemia can be serious and may require hospitalization or glucose administration. This medication should not be used in patients with diabetic ketoacidosis, diabetic coma, type 1 diabetes, or severe liver or kidney dysfunction. Additionally, it should be avoided in patients with severe infections, trauma, or those undergoing surgery, as well as patients with gastrointestinal disorders. Patients who have had allergic reactions to this drug or similar drugs, pregnant or breastfeeding women, and those taking specific antifungal medication such as miconazole should not use this medication. It should also not be administered to patients with genetic lactose intolerance. Elderly patients at high risk of hypoglycemia, those with weakened kidney or liver function, patients with endocrine disorders, those with poor nutritional status or irregular meals, intense exercise participants, and habitual excessive drinkers should use this medication cautiously. While taking this medication, blood glucose and urine sugar tests should be conducted regularly to monitor efficacy and side effects, and if symptoms of hypoglycemia appear, carbohydrates should be consumed immediately. Symptoms of hypoglycemia include weakness, headache, trembling, confusion, sleepiness, and in severe cases, may lead to coma. This medication may interact with various drugs, so if taking other medications, it is essential to consult a doctor or pharmacist. Women who are pregnant or planning to become pregnant should not use this medication, nor should breastfeeding women. Safety in children has not been established, and elderly patients need to exercise extra caution due to a higher risk of hypoglycemia. In case of overdose, symptoms of hypoglycemia may appear; therefore, if there is loss of consciousness or severe symptoms, immediate medical attention is required. Caution should be taken regarding symptoms of hypoglycemia while driving or operating machinery. Store this medication out of reach of children and do not transfer it to another container.

Serious side effects

Hives, severe swelling (edema), angioedema, chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, rash with high fever, blisters, skin peeling, pain in the oral/ocular mucosa, severe skin reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by coughing + fever, yellowing of the skin or eyes (jaundice), extreme drowsiness, liver abnormalities (jaundice), sudden

Mild side effects

• Weakness
• intense hunger
• tremor
• headache
• abnormal sensation
• agitation
• decreased concentration
• aggression
• nausea
• vomiting

This medication should be stored in a tightly sealed container that is air-tight, at room temperature between 1 degree and 30 degrees Celsius. Storing it this way will help maintain the drug's efficacy for a long time.

Appearance

White round tablet

Package unit

30 tablets/bottle, 300 tablets/bottle